Vascular Disease Management
INSIGHT INTO DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE
MANAGEMENT
Thursday, May 15, 2008

SEARCH ARTICLES



Home | About
Current Issue
Archives
Subscribe
Board Members
Search Article Archives
Editor's Update
Events & Symposia
Industry News | Enews
Discussion Forum
Classifieds
Letter to the Editor
Comments/Suggestions
Editorial/Production
Author Information
Submit a Manuscript
Review a Manuscript
Order Article Reprints
Advertising
Advertising Specs
Online/Web Production

Featured Article

387
Vascular Disease Management - ISSN: 1553-8036 - Volume 2 - Issue 3 - May 2005
Frank J. Criado
David Nicholson, MD, Gary M. Ansel, MD, Charles F. Botti, Jr., MD, Mitchell J. Silver, MD

De Novo Periaortitis Following Endovascular Aneurysm Repair: A report of two cases
Vasana Cheanvechai, MD and Steve Busuttil, MD

Commentary
Richard Heuser, MD

Emergency Stent-graft Repair for Thoracic Aortic Injury
1Patrizio Castelli, MD, 1Roberto Caronno, MD, 1Gabriele Piffaretti, MD, 1Matteo Tozzi, MD, 1Chiara Lomazzi, MD, 2Domenico Laganà, MD, 2Gianpaolo Carrafiello, MD, 3Salvatore Cuffari, MD
Objective. Blunt traumatic thoracic aortic disruption results in pre-hospital death in 80% to 90% of patients. Surgical repair has been the standard method throughout the past decades, but early postoperative mortality is still reported to range from 7.7–28%. More recently, an increasing number of reports have advocated endovascular treatment. We report our experience with emergency endovascular treatment of thoracic aortic disruptions treated with a commercially available stent graft. Methods. In the last three years, seven patients with a median age of 26 years (mean: 26.8 ± 9.2 years, range 18–45) with multiple system trauma after motor vehicle accidents were treated on an emergency basis for acute blunt thoracic aortic rupture. All patients presented with multiple co-existing injuries. The mean Injury Severity Score (ISS) score was 42.7 ± 29 (range, 4–75; median 50). Chest X-ray findings warranted CT-angiography scans, which revealed disruptions of the thoracic aorta, identi

Commentary
Frank J. Criado, MD

Cutting Balloon Angioplasty for the Treatment of Stenosis in Hemodialysis Arteriovenous Fistulas
Gianpaolo Carrafiello, MD, Domenico Laganá, MD, Monica Mangini, MD, Chiara Recaldini, MD, Domenico Lumia, MD, Andrea Giorgianni, MD, Carlo Fugazzola, MD
Objective. To assess the effectiveness of cutting balloon angioplasty in the treatment of stenosis in hemodialysis arteriovenous fistulas (AVF). Materials and Methods. Over the past two years, we have observed 75 patients with hemodialysis AVFs. Twenty-one patients (mean age 66.4 years, range 51–81) with AVF stenosis (19 Cimino-Brescia fistulas and 2 loop grafts) were selected for cutting balloon angioplasty. In 10 cases, the cutting balloon device was used after failure of dilatation with a high-pressure balloon, while in 11 cases (9 focal stenosis and 2 restenosis), it was used as a primary approach. We utilized cutting balloons with the following diameters: 8 mm (n = 2), 6 mm (n = 10), 5 mm (n = 8) and 4 mm (n = 1). The follow-up was performed by color Doppler ultrasound (CDU) and clinical evaluation at 1, 3, 6, 12, 18 and 24 months. Results. In all patients, the post-procedure angiography demonstrated an immediate technical success. No peri-procedural complications occurred.

Optimal Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: New insights from the randomized ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study
1Giuseppe Patti, MD, 2Vincenzo Pasceri, MD, 1Germano Di Sciascio, MD

Commentary: Optimal Antiplatelet Therapy: Lessons Learned from PCI Applicable to PAD and PPI
David E. Allie, MD

Commentary: Achieving Optimal Platelet Inhibition During Percutaneous Coronary Interventions
Nicholas W. Shammas, MS, MD
From the Midwest Cardiovascular Research Foundation, Genesis Heart Institute Affiliate, Cardiovascular Medicine, PC, Davenport, Iowa. Address for correspondence: Nicolas W. Shammas, MD, FACC. Research Director, Midwest Cardiovascular Research Foundation, Genesis Heart Institute Affiliate, Cardiovascular Institute Medicine, PC, 1236 E. Rusholme, Suite 300, Davenport, Iowa 52803.

New Device Trials: The United States Multicenter Experience with the Powerlink: A review
Jeffrey P. Carpenter, MD on behalf of the Endologix Investigators*

Exclusion of a Renal Artery Aneurysm with a Viabahn Self-expanding Covered Stent
Jeffrey P. Schussler, MD and Kenneth B. Johnson, MD
A 75-year-old man, with history of atherosclerotic coronary artery disease, was referred to our institution for management of a ~2 cm renal artery aneurysm. Repair was performed using a novel, self-expanding, nitinol stent which is lined with PTFE. This type of stent has had utility in repair of ruptured vessels, and several case reports have described its use in the exclusion of different types of vascular aneurysms. We describe the first case of renal artery aneurysm exclusion using a self-expanding covered stent. Vascular Disease Management 2005;2:39-42. Keywords: Hemobahn, nitinol, bivalirudin, IVUS, ePTFE, stent-graft

VASCULAR TOPICS

Peripheral Angioplasty
Thoracic Stent Grafts
Renal Stenting
Vena Cava Filter
Hemodialysis Management
Computed Tomography
PFO Closure
SFA Stenting
Carotid Stenting
Vessel Closure
Angiography
Carotid Endarterectomy
Ultrasound

Critical Limb Ischemia
Superficial Femoral Artery
Embolization
Device Based Thrombectomy
Pharmacological Management
MRA
Mesenteric Artery Stenting
AAA Stent Grafts
Iliac Stenting
Thrombolysis Procedures Using Drug Therapy

SUPPLEMENTS

Superior Mesenteric Artery Revascularization and Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

HMP Increased Cutaneous Sensibility in Patients with Diabetic Neuropathy Utilizing a Pharmacological Approach — Clinical Case Evidence

This clinical case update was supported through an unrestricted educational grant from Pamlab, LLC.

A New Biological Approachto Below-Knee Revascularization
A Review of the GORE PROPATEN Vascular Graft:
The Combination That Lasts

This special supplement was made possible through a grant from W. L. Gore

Combining Bilayered Living Cell Therapy with Minimally Invasive Vein Surgery:
Current Treatment Strategies for Venous Ulcers

This activity is supported by an educational grant from Organogenesis.

Pharmacotherapy in Peripheral Vascular Disease

Platelet Inhibition in Critical Limb Ischemia and Peripheral Vascular Interventions
DAVID E. ALLIE, MD

An Overview of Pharmacotherapy during Percutaneous Peripheral Interventions of Thrombotic Lesions
NICOLAS W. SHAMMAS, MD, MS, FACC


The Important Properties of Contrast Media: Focus on Viscosity

This special supplement was made possible through a grant from Guerbet LLC

RECENTLY ADDED

Anticoagulation Techniques for Peripheral Vascular Interventions

Archived Webcast





© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd., Suite 100, Malvern, PA 19355
Phone: 800.237.7285 610.560.0500 Fax: 610.560.0502
Privacy Policy